Faes Farma SA (FAE):企業の財務・戦略的SWOT分析

◆英語タイトル:Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0985
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Faes Farma SA (FAE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and finished pharmaceutical products to pharmaceutical companies worldwide. Faes Farma also owns Ingaso farm, the animal nutrition and healthcare company. The company operates R&D center in Bilbao, Spain; a laboratory in Lisbon and production plants, subsidiaries and commercial offices in international markets. The company markets the products in Latin America, Asia, Europe, Africa and the Middle East. Faes Farma is headquartered in Madrid, Spain.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Faes Farma SA – Key Facts
Faes Farma SA – Key Employees
Faes Farma SA – Major Products and Services
Faes Farma SA – History
Faes Farma SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Faes Farma SA – Business Description
R&D Overview
Faes Farma SA – Corporate Strategy
Faes Farma SA – SWOT Analysis
SWOT Analysis – Overview
Faes Farma SA – Strengths
Faes Farma SA – Weaknesses
Faes Farma SA – Opportunities
Faes Farma SA – Threats
Faes Farma SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Faes Farma SA, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Faes Farma SA, Key Facts
Faes Farma SA, Key Employees
Faes Farma SA, Major Products and Services
Faes Farma SA, History
Faes Farma SA, Subsidiaries
Faes Farma SA, Affiliate
Faes Farma SA, Key Competitors
Faes Farma SA, Ratios based on current share price
Faes Farma SA, Annual Ratios
Faes Farma SA, Annual Ratios (Cont...1)
Faes Farma SA, Annual Ratios (Cont...2)
Faes Farma SA, Interim Ratios
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Faes Farma SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Faes Farma SA, Performance Chart (2014 - 2018)
Faes Farma SA, Ratio Charts
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Faes Farma SA (FAE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Realm Therapeutics Plc (RLM):製薬・医療:M&Aディール及び事業提携情報
    Summary Realm Therapeutics Plc (Realm Therapeutics), formerly PuriCore Plc is a biopharmaceutical company that develops small molecule therapies for diseases. The company uses its immunomodulatory technology for treating inflammatory diseases in dermatology, ophthalmology, and other diseases. Its pi …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • NGK INSULATORS, LTD.:企業の戦略・SWOT・財務情報
    NGK INSULATORS, LTD. - Strategy, SWOT and Corporate Finance Report Summary NGK INSULATORS, LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Astex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • ZIOPHARM Oncology Inc (ZIOP):企業の財務・戦略的SWOT分析
    Summary Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy for cold tumors by turning them hot by activating an immune resp …
  • Chubu Electric Power Co Inc (9502)-石油・ガス分野:企業M&A・提携分析
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity from nuclear, hydro, solar, biomass, wind, coal, fuel oil, and natural gas sources. Chubu has interests in upstream …
  • MKB Private Banking:企業の戦略・SWOT・財務分析
    MKB Private Banking - Strategy, SWOT and Corporate Finance Report Summary MKB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Expro Holdings UK 2 Limited:企業の戦略的SWOT分析
    Expro Holdings UK 2 Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Gerdau S.A. (GGBR4):企業の財務・戦略的SWOT分析
    Gerdau S.A. (GGBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Companhia de Eletricidade do Estado da Bahia SA (CEEB5):企業の財務・戦略的SWOT分析
    Summary Companhia de Eletricidade do Estado da Bahia SA (COELBA) is a power distribution company that offers electricity services. The company's services include power supplying, electrical damage, shutdown consumer unit, load change, debts information, microgeneration connection and power minigener …
  • Wilmar International Limited:企業の戦略・SWOT・財務情報
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Omron Healthcare Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Global Telecom Holding S.A.E.:企業の戦略・SWOT・財務情報
    Global Telecom Holding S.A.E. - Strategy, SWOT and Corporate Finance Report Summary Global Telecom Holding S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆